PharmaVOICE - 
March 2006
Purchase Issue
In Every Issue
The Perfect Job Is There For The Asking Contributed by [...]

Shellie Caplan

the winner is … HBA 2006 Woman of the Year [...]
Regulatory Deficiency is High Among Non-U.S. Clinical Investigators In a [...]
What’s New
New Prescription Drug Information Format to Improve Patient Safety The [...]
For Art’s Sake
Each month, this department pays homage to memorable advertising and [...]
Letter from the Editor
Anybody who has a parent or parents who are in [...]

Taren Grom, Editor

Elsevier MDL Introduces Electronic Lab Notebook Elsevier MDL has launched [...]
Talent Pool
Pharma POOL Robert H. Armstrong Dr. Steven Caffe Baxter Names [...]
On the Calendar
Mach 2006 On the Calendar March 20-21 2nd Annual Pharmaceutical [...]

On The Cover

Managing Marketing Under Medicare Part D
Medicare Part D presents many opportunities, as well as challenges, for pharmaceutical marketers. As the industry adapts its marketing strategies for this evolving arena, transparency is a top priority. Brand teams also need to remain flexible and stay on top of emerging information and trends to best position their products. Compliance Concerns With the increase [...]

Elisabeth Pena Villarroel


The Value of Journal Advertising
By Autumn Konopka Advertising in medical journals, while underused in the past according to most experts, does provide value to pharmaceutical marketers. Experts say recent industry trends are likely to encourage pharma companies to focus more of their efforts on journal advertising in the future. Pe for their advertising. Robert Osborn Jr. President rofessional medical [...]

Autumn Konopka

Prescription for Success in Globalization
Prescription for Success in Globalization VIEW on a common global language Sig Shirodkar, Principal, and Mark Mozeson, Principal and life sciences Practice Leader, both of Archstone Consulting, discuss why designing a set of corporate attributes and standards of behavior is the key to global success. As pharmaceutical organizations trend Pharmaceutical organizations, much like firms in [...]
A World Vision — Prof. Paul Herrling
By Kim Ribbink Paul Herrling, head of corporate research at Novartis, appreciates the multidimensionality of life, whether he is conducting experiments in the lab or overseeing corporate decisions. He extends this view to medicine while creating an environment that strives for collaboration and diversity Paul Herrling, Ph.D., appreciates the intricacy and multidimensionality of life, whether [...]

Kim Ribbink

Shifting the Pediatrics Paradigm
By Autumn Konopka The FDA’s push for pediatric studies since the late 1990s has nearly doubled the pediatrics market, which is expected to keep growing in the coming years. Nevertheless, children remain “therapeutic orphans,” and some experts believe that the pediatrics market may never be able to sustain itself without governmental incentives. Dr. Cameron Durrant [...]

Autumn Konopka